White Papers + Downloads

The HempNut Book

This is the original version of the 2nd edition cookbook except without the recipes, but including a Glossary with 48 terms and full Bibliography with 514 references. It was what was sent to the publisher before it was edited to fit into 192 pages printed. I’m offering this version free as it’s a great reference book, with hempseed history, nutritional info, and more. 80 pages, PDF. FREE.

Cost of Goods Sold Analysis Model

A Cost of Goods Sold Analysis Model by Richard Rose. Excel file. For calculating total direct cost of goods of a product, including packaging, shipping, box, gross profit margins, suggested retail prices, etc. The values are useless to you, as the formulas are where the magic happens. Just add your products and data. FREE, $999 value.

Cash Flow Analysis Model

A Cash Flow Analysis Model by Richard Rose. Excel file. For forecasting cash flow for three years, sales less cost of goods sold less selling expenses less operating expenses shows you gross profit, net profit and net cash, and percentages. The values are useless to you, as the formulas are where the magic happens. Just add your products and data. FREE, $999 value.

The HempNut Cookbook (both editions)

Here’s a free download of my The HempNut Cookbook, both editions combined. 200 recipes, 180 pages, tons of original historical and nutritional information. Perhaps the first consumer mention of CBD (2000).

FDA Report on CBD to Congress

Report to the U.S. House Committee on Appropriations and the U.S. Senate Committee on Appropriations on Cannabidiol (CBD) by U.S. Food and Drug Administration.

On December 20, 2019, the Further Consolidated Appropriations Act, 2020 (P.L. 116-94), was enacted into law, which provided FDA with appropriations under Division B, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Act, 2020, for the fiscal year ending September 30, 2020. The accompanying Joint Explanatory Statement directed the Food and Drug Administration (FDA or the Agency) to report on Cannabidiol (CBD):
“Within 60 days of enactment of this Act, the FDA shall provide the Committees with a report regarding the agency’s progress toward obtaining and analyzing data to help determine a policy of enforcement discretion and the process in which CBD meeting the definition of hemp will be evaluated for use in products.” In response to this directive, FDA prepared the following report. 18 pages.

Download
Download
Download
Download
Download
Download
Download

Download
Download
Download
Download
Download
Download
Download
Download
Download
Download
Download
Download

Download
Download
Download
Download
Download
Download
Download
Download
Download
Download
Download
Download
Download
Download
Download
Download
Download
Download
Download

Download
Download
Download
Download
Download
Download
Download
Download
Download
Download

Leave Your Reply Cancel reply

Copyright 1994-2023 Richard Rose, all rights reserved. Any views expressed herein are the personal opinion of Richard Rose. This is a noncommercial public service. There are no warranties whatsoever as to the legality, suitability, ownership, purpose, or accuracy of this information. I am not a doctor or a lawyer. If you have medical questions, please seek a medical professional. If you have legal questions, please seek a legal professional. Information found here is not intended to diagnose, cure, treat, or prevent any disease. These statements and subsequent links found here have not been evaluated by the U.S. Food and Drug Administration (FDA). Hemp is not subject to international drug controls and is grown legally around the world. The information posted here is for educational purposes only and is not to be considered legal or medical advice, and is not intended to replace consultation with a qualified legal or medical professional. This website uses cookies. By continuing to use this service, you agree to their use. This is provided on an “as is,” “as available” basis without warranties of any kind, express or implied. The user assumes all responsibility and risk for the use of this website. Links are provided only as an informational resource, and it should not be implied that we own, recommend, endorse or approve of any of the content at the linked sites, nor are we responsible for their content. Unless otherwise stated, nobody pays us nuttin’ to post content, and we have no sponsors unlike NASCAR. By providing your email address to us you agree to be on the free The Richard Rose Report mailing list; you may unsubscribe at any time. There is no charge. To learn more about how we collect, keep, and process your private information in compliance with GDPR, please view our privacy policy via a link at the bottom of this page. Void where prohibited. Specifications subject to change without notice. If you don’t agree with the above please leave immediately. “HempNut,” “The Hemp Nut,” “Hempeh,” “HempRella,” “Not-Pot,” “Nobacco,” “CannaSearch,” “CannaSearch Daily,” “CannaSearch Breaking News,” “The HempNut Cookbook,” “The Richard Rose Report,” “Medicinal Hemp Association,” “Hemp Flower Products Association,” “CannLib,” “CannLib Search,” and the rest of my intellectual property are trademarks, service marks, and/or copyrights of Richard Rose, all rights reserved. All patents, service marks, trademarks, and copyrights are the property of their respective owners. To the best of my knowledge, all Articles, Downloads, and Posts authored by RR are absolutely not written with any type of AI, just a human brain. Grammarly and autocorrect might be used to make minor edits. Posts authored under CannaSearch Daily are written by the original external poster, and no claim is made for those. It’s obvious that GPT language models will be deployed everywhere, but their accuracy is still low so I avoid them for now. Plus writers write.

Does drug use affect the efficacy of amisulpride, aripiprazole and olanzapine in patients with schizophrenia spectrum disorders? Results from a pragmatic, randomised study June 3, 2023
CONCLUSION: The current study showed that drug use does not appear to affect the overall effectiveness of amisulpride, aripiprazole and olanzapine in patients with SSD. However, amisulpride may be a particularly suitable choice for older patients with drug use.
Renata Alisauskiene
Comprehensive characterization of volatile and semi-volatile compounds in e-liquids for electronic cigarette using gas chromatography accurate mass spectrometry June 3, 2023
The consumption of electronic cigarettes is a habit with an increasing prevalence, particularly among youths. Knowing the composition of e-liquids used in these devices represents the first step to understand the potential impact of e-smoking in the health of consumers. Herein, a non-target screening methodology was applied to the identification of volatile and semi-volatile compounds […]
M Cobo Golpe
First use of cannabis compared to first use of alcohol and tobacco: Associations with single and poly-substance use behavior June 3, 2023
CONCLUSIONS: Cannabis initiation before alcohol and tobacco is uncommon and may even protect against future alcohol use. Deterring cannabis initiation with multiple substances could have public health benefits.
Amy M Cohn
A systematic review and meta-analysis of the association between young adults' sleep habits and substance use, with a focus on self-medication behaviours June 3, 2023
Young adults (18-30 years) are vulnerable to sleep-wake disturbances and substance use, which are bi-directionally associated. The present work aims to organise the literature that deals with the association between sleep and substance use in young adults, also considering self-medication behaviours. We adopted a framework that accounts for the multidimensionality of sleep and the effect […]
Debora Meneo
Assessing the impact of a major electronic music festival on the consumption patterns of illicit and licit psychoactive substances in a Mediterranean city using wastewater analysis June 3, 2023
The consumption patterns of five categories of psychoactive substances (PS), including "conventional" illicit drugs, new psychoactive substances (NPS), therapeutic opioids, alcohol and nicotine, were studied in the city of Split, Croatia, using wastewater-based epidemiology (WBE), with an emphasis on the impact of a large electronic music festival. The study involved the analysis of 57 urinary […]
Ivan Senta
Hexahydrocannabinol and closely related semi-synthetic cannabinoids: A comprehensive review June 3, 2023
Since the early 2000s, there has been a turmoil on the global illicit cannabinoid market. Parallel to legislative changes in some jurisdictions regarding herbal cannabis, unregulated and cheap synthetic cannabinoids with astonishing structural diversity have emerged. Recently, semi-synthetic cannabinoids manufactured from hemp extracts by simple chemical transformations have also appeared as recreational drugs. The burst […]
István Ujváry
Chronic Δ9-tetrahydrocannabinol treatment has dose-dependent effects on open field exploratory behavior and [<sup>3</sup>H] SR141716A receptor binding in the rat brain June 3, 2023
AIMS: Acute and chronic Δ⁹-THC exposure paradigms affect the body differently. More must be known about the impact of chronic Δ⁹-THC on cannabinoid-1 (CB1R) and mu-opioid (MOR) receptor levels in the brain. The present study examined chronic Δ⁹-THC's effects on CB1R and MOR levels and locomotor activity.
Lily Freeman-Striegel
Retraction notice to "Hemp bioactive peptides: Nutrition, functional properties and action mechanisms to maximize their nutraceutical applications and future prospects" [Food Chemistry 414 (2023) 135691] June 3, 2023
No abstract
Tolulope Joshua Ashaolu
Cannabis use, cannabis use disorder and mental health disorders among pregnant and postpartum women in the US: A nationally representative study June 2, 2023
CONCLUSIONS: From pregnancy up to one year postpartum is a critical period where women may be particularly vulnerable to mental health disorders, cannabis use and CUD. Treatment and prevention are essential.
Qiana L Brown
Impact of Prenatal Cannabis Use Disorder on Perinatal Outcomes June 2, 2023
CONCLUSIONS: Our study suggests that prenatal cannabis use disorder is associated with increased maternal and neonatal morbidity and mortality. As cannabis use disorder in pregnancy is becoming more prevalent, our findings can help guide preconception and prenatal counseling.
Kristin C Prewitt
Associations Between Distinct Co-occurring Substance Use Disorders and Receipt of Medications for Opioid Use Disorder in the Veterans Health Administration June 2, 2023
CONCLUSIONS: In this study of national VA outpatients with OUD, those with certain co-occurring SUDs were less likely to initiate or continue MOUD. Further research is needed to identify barriers related to specific co-occurring SUDs.
Madeline C Frost
Sex Differences in the Pharmacokinetics of Cannabidiol and Metabolites Following Oral Administration of a Cannabidiol-Dominant Cannabis Oil in Healthy Adults June 2, 2023
Introduction: Oral cannabidiol (CBD) product use is increasingly growing among women; however, there is a lack of data on sex differences in the pharmacokinetics (PKs) of CBD and its primary metabolites, 7-hydroxy-CBD (7-OH-CBD) and 7-carboxy-CBD (7-COOH-CBD), after repeated doses. Materials and Methods: The present study is a secondary analysis of data from a randomized, double-blind, […]
Laura MacNair
Was retrospective change measurement conducted with Covid-19 containment inconsistent? Comparing prospective and retrospective change measures using data from a national survey on substance use and addictive behaviors June 2, 2023
Single-measurement-point data collection to assess change has increased with studies assessing the impact of the Covid-19 pandemic and of its containment, despite evidence of its lack of validity. Retrospective change is not equivalent to change in repeated self-reported measures giving raise to questions about the validity of the former. This paper purports to investigate inconsistencies […]
Marc Dupuis
Acetylcholinesterase inhibitors for autistic spectrum disorders June 2, 2023
BACKGROUND: Autism spectrum disorder (autism) is a neurodevelopmental condition characterised by impairments in social communication and interaction, plus restricted, repetitive patterns of behaviour and interests. Whilst some people embrace autism as part of their identity, others struggle with their difficulties, and some seek treatment. There are no current interventions that result in complete reduction of […]
Alexandra Ure
Δ9-Tetrahydrocannabinol Treatment Modifies Insulin Secretion in Pancreatic Islets from Prediabetic Mice Under Hypercaloric Diet June 2, 2023
Background: The endocannabinoid system over-activation is associated with type-2 diabetes mellitus onset, involving physiological, metabolic, and genetic alterations in pancreatic islets. The use of Δ9-Tetrahydrocannabinol (THC) as treatment is still controversial since its effects and mechanisms on insulin secretion are unclear. The aim of this study was to evaluate the effects of THC treatment in […]
Guadalupe M Garcia-Luna
Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling June 2, 2023
There have been significant advances in the treatment of cancer in the past decade. However, patients continue to suffer from significant side effects of antineoplastic agents that greatly affect their quality of life (QOL), including chemotherapy-induced nausea and vomiting (CINV), chemotherapy-induced peripheral neuropathy (CIPN), and chemotherapy-induced alopecia (CIA). This review aims to provide an updated […]
Alissa Michel
In vitro, ex vivo, and clinical evaluation of anti-aging gel containing EPA and CBD June 2, 2023
BACKGROUND: Skin aging manifestation, such as coarse wrinkles, loss of elasticity, pigmentation, and rough-textured appearance, is a multifactorial process that can be exacerbated by air pollution, smoking, poor nutrition, and sun exposure. Exposure to UV radiation is considered the primary cause of extrinsic skin aging and accounts for about 80% of facial aging. Extrinsic skin […]
Guy Cohen
Assessing the Impact of Recreational Cannabis Legalization on Cannabis Use Disorder and Admissions to Treatment in the United States June 2, 2023
PURPOSE OF REVIEW: Policy implications from changes in recreational cannabis laws (RCLs) have raised public health concerns. While numerous studies have examined the impact of RCLs on cannabis use, there is less research on the risk of developing cannabis use disorder (CUD). This review summarizes the latest research on the effects of RCLs on CUD […]
Lydia Aletraris
Adolescent exposure to low-dose THC disrupts energy balance and adipose organ homeostasis in adulthood June 2, 2023
One of cannabis' most iconic effects is the stimulation of hedonic high-calorie eating-the "munchies"-yet habitual cannabis users are, on average, leaner than non-users. We asked whether this phenotype might result from lasting changes in energy balance established during adolescence, when use of the drug often begins. We found that daily low-dose administration of cannabis' intoxicating […]
Lin Lin
Impact of cannabis on outcome in patients following traumatic injury June 2, 2023
CONCLUSION: Cannabis was not associated with overall in-hospital mortality or morbidity. There was a slight decrease in the incidence of PE in the cannabis positive group.
Nasim Ahmed